PLIVA 456 (Oxybutynin 5 mg)
Pill imprint PLIVA 456 has been identified as Oxybutynin chloride 5 mg.
Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; dysuria; hyperhidrosis; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about oxybutynin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 200 Reviews – Add your own review/rating
- Drug class: urinary antispasmodics
- Oxybutynin extended-release tablets
- Oxybutynin gel
- Oxybutynin syrup
- Oxybutynin system
- More... (4)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.